Morgan Stanley’s Diebold Nixdorf Incorporated DBD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,534,001
Closed -$1.84M 7775
2023
Q1
$1.84M Buy
1,534,001
+951,138
+163% +$2.12M ﹤0.01% 4509
2022
Q4
$828K Sell
582,863
-536,677
-48% -$1.15M ﹤0.01% 4968
2022
Q3
$2.73M Buy
1,119,540
+67,670
+6% +$226K ﹤0.01% 4210
2022
Q2
$2.39M Buy
1,051,870
+379,695
+56% +$1.41M ﹤0.01% 4393
2022
Q1
$4.52M Buy
672,175
+208,226
+45% +$1.78M ﹤0.01% 3794
2021
Q4
$4.2M Sell
463,949
-41,514
-8% -$386K ﹤0.01% 3897
2021
Q3
$5.11M Sell
505,463
-24,541
-5% -$269K ﹤0.01% 3675
2021
Q2
$6.8M Buy
530,004
+267,166
+102% +$3.66M ﹤0.01% 3446
2021
Q1
$3.71M Sell
262,838
-152,409
-37% -$2.1M ﹤0.01% 3721
2020
Q4
$4.43M Buy
415,247
+172,916
+71% +$1.57M ﹤0.01% 3390
2020
Q3
$1.85M Sell
242,331
-34,520
-12% -$254K ﹤0.01% 3719
2020
Q2
$1.68M Buy
276,851
+49,869
+22% +$246K ﹤0.01% 3759
2020
Q1
$799K Sell
226,982
-205,058
-47% -$1.74M ﹤0.01% 4106
2019
Q4
$4.56M Sell
432,040
-100,493
-19% -$892K ﹤0.01% 3293
2019
Q3
$5.96M Buy
532,533
+154,544
+41% +$1.83M ﹤0.01% 2671
2019
Q2
$3.46M Buy
377,989
+126,681
+50% +$1.32M ﹤0.01% 3295
2019
Q1
$2.78M Buy
251,308
+76,848
+44% +$537K ﹤0.01% 3299
2018
Q4
$434K Sell
174,460
-1,805
-1% -$6.47K ﹤0.01% 4871
2018
Q3
$793K Sell
176,265
-286,008
-62% -$2.09M ﹤0.01% 4703
2018
Q2
$5.52M Sell
462,273
-274,844
-37% -$3.68M ﹤0.01% 3034
2018
Q1
$11.4M Sell
737,117
-475,054
-39% -$7.93M ﹤0.01% 2224
2017
Q4
$19.8M Buy
1,212,171
+611,515
+102% +$11.8M 0.01% 1674
2017
Q3
$13.7M Buy
600,656
+171,214
+40% +$3.65M ﹤0.01% 1956
2017
Q2
$12M Sell
429,442
-23,947
-5% -$663K ﹤0.01% 1994
2017
Q1
$13.9M Buy
453,389
+15,565
+4% +$440K ﹤0.01% 1893
2016
Q4
$11M Buy
437,824
+303,476
+226% +$7.16M ﹤0.01% 2148
2016
Q3
$3.33M Buy
134,348
+61,030
+83% +$1.62M ﹤0.01% 3062
2016
Q2
$1.82M Buy
73,318
+31,707
+76% +$816K ﹤0.01% 3501
2016
Q1
$1.2M Sell
41,611
-120,982
-74% -$3.16M ﹤0.01% 3781
2015
Q4
$4.89M Buy
162,593
+21,635
+15% +$735K ﹤0.01% 2679
2015
Q3
$4.2M Buy
140,958
+40,574
+40% +$1.32M ﹤0.01% 2807
2015
Q2
$3.51M Buy
100,384
+38,646
+63% +$1.36M ﹤0.01% 3116
2015
Q1
$2.19M Sell
61,738
-4,693
-7% -$158K ﹤0.01% 3522
2014
Q4
$2.3M Buy
66,431
+19,600
+42% +$691K ﹤0.01% 3452
2014
Q3
$1.65M Sell
46,831
-70,509
-60% -$2.66M ﹤0.01% 3590
2014
Q2
$4.71M Sell
117,340
-4,177
-3% -$160K ﹤0.01% 2714
2014
Q1
$4.85M Sell
121,517
-120,347
-50% -$4.33M ﹤0.01% 2603
2013
Q4
$7.98M Buy
241,864
+18,301
+8% +$571K ﹤0.01% 2128
2013
Q3
$6.56M Buy
223,563
+14,880
+7% +$467K ﹤0.01% 2159
2013
Q2
$7.03M Buy
+208,683
New +$6.46M ﹤0.01% 2005

Other funds holding DBD

Morgan Stanley's DBD Position: Q2 2023 in Review

Morgan Stanley sold out of Diebold Nixdorf Incorporated (DBD) in Q2 2023, closing a stake of 1,534,001 shares — an estimated $1.84M sold.

Morgan Stanley first reported a position in DBD in Q2 2013 and held it in 40 quarters. The position peaked at $19.8M in Q4 2017. 7 funds tracked by Wall St. Rank hold DBD as of Q2 2023.

  • Morgan Stanley reported no remaining Diebold Nixdorf Incorporated position as of Q2 2023 after selling out during the quarter.
  • Morgan Stanley sold 1,534,001 Diebold Nixdorf Incorporated shares in Q2 2023, an estimated $1.84M.
  • Morgan Stanley first reported a position in Diebold Nixdorf Incorporated in Q2 2013 and held it in 40 quarters.
  • Morgan Stanley's Diebold Nixdorf Incorporated position peaked at $19.8M in Q4 2017.
  • 7 funds tracked by Wall St. Rank held Diebold Nixdorf Incorporated as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.